A combined measles, mumps, rubella and varicella vaccine (Priorix-Tetra™): Immunogenicity and safety profile

This publication has 44 references indexed in Scilit:

• Varicella Vaccination in Japan, South Korea, and Europe
  The Journal of Infectious Diseases, 2008
• Safety and Immunogenicity of Early Vaccination with Two Doses of Tetravalent Measles-Mumps-Rubella-Varicella (MMRV) Vaccine in Healthy Children from 9 Months of Age
  Infection, 2007
• Increasing Coverage and Efficiency of Measles, Mumps, and Rubella Vaccine and Introducing Universal Varicella Vaccination in Europe
  The Pediatric Infectious Disease Journal, 2007
• Varicella vaccination in Europe: are we ready for a universal childhood programme?
  European Journal of Pediatrics, 2007
• Varicella
  The Lancet, 2006
• Decline in Mortality Due to Varicella after Implementation of Varicella Vaccination in the United States
  New England Journal of Medicine, 2005
• Decline in Varicella-Related Hospitalizations and Expenditures for Children and Adults After Introduction of Varicella Vaccine in the United States
  Pediatrics, 2004
• Ten year follow-up of healthy children who received one or two injections of varicella vaccine
  The Pediatric Infectious Disease Journal, 2004
• Reactogenicity and immunogenicity of a live attenuated tetravalent measles–mumps–rubella–varicella (MMRV) vaccine
  Vaccine, 2002
• Varicella Disease After Introduction of Varicella Vaccine in the United States, 1995-2000
  JAMA, 2002